AVITA Medical (RCEL) Other Non-Current Liabilities (2019 - 2026)
AVITA Medical's (RCEL) quarterly Other Non-Current Liabilities came in at $1.2 million in Q4 2025, down 58.57% YoY from $3.0 million in Q4 2024, and down 33.17% on a QoQ basis from $1.9 million in Q3 2025.
AVITA Medical (RCEL) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 6 years of Other Non-Current Liabilities data on file, last reported at $1.2 million in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 58.57% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 58.57% YoY) and the FY2025 annual result came in at $1.2 million, down 58.57% from the prior year.
- Other Non-Current Liabilities retreated to $1.2 million in Q4 2025, from $1.9 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $4.0 million in Q1 2024 to a low of $19000.0 in Q1 2021.
- A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 2905.26% — and 2025, when it plunged 58.57%.
- Tracing RCEL's Other Non-Current Liabilities over 5 years: stood at $113000.0 in 2021, then surged by 1092.92% to $1.3 million in 2022, then jumped by 134.27% to $3.2 million in 2023, then dropped by 5.0% to $3.0 million in 2024, then sank by 58.57% to $1.2 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $1.2 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | AVITA Medical | 310.57 Mn | 299.44 Mn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 879,000.00 |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Jun 30, 2022 | 715,000.00 |
| Mar 31, 2022 | 571,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | 503,000.00 |
| Jun 30, 2021 | 503,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Jun 30, 2019 | 42,000.00 |